Secondary Metabolites from Castanea mollissima Leaves: α-Glucosidase and PTP1B Inhibition, Suppression of LPS-Induced Nitric Oxide Production, and Molecular Docking Analysis
Аннотация
Type 2 diabetes involves postprandial hyperglycemia, impaired insulin signaling, and inflammation. Phytochemical investigation of Castanea mollissima Blume, Fagaceae, leaves yielded eight known secondary metabolites, whose structures were established using 1D and 2D NMR data. All isolates were evaluated for α-glucosidase and protein tyrosine phosphatase 1B (PTP1B) inhibition, while fucosterol, bergenin, 4-hydroxy-2-methoxyphenol-β- d -{3″- O -[4′-hydroxy-3′-methoxy(benzoate)]}-glucopyranoside, and vitexin were additionally tested for suppression of lipopolysaccharide-induced nitric oxide production in RAW264.7 macrophages. Compounds 1β,4β,7α-trihydroxyeudesmane, fucosterol, bergenin, and 4-hydroxy-2-methoxyphenol-β- d -{3″- O -[4′-hydroxy-3′-methoxy(benzoate)]}-glucopyranoside are reported for the first time from C. mollissima . Fucosterol was the most active constituent across the three assays, inhibiting nitric oxide (IC 50 19.6 ± 0.4 μM), α-glucosidase (IC 50 38.9 ± 2.9 μM), and PTP1B (IC 50 7.1 ± 1.2 μM) production. Vitexin and rutin showed moderate α-glucosidase inhibition, whereas the remaining compounds were weak or inactive. Molecular docking against inducible nitric oxide synthase, cyclooxygenase-2, interleukin-8, oligo-1,6-glucosidase, and PTP1B provided hypothesis-generating information on possible ligand-target interactions. These findings expand the known secondary-metabolite profile of C. mollissima and support further investigation of fucosterol. Graphical Abstract